Spashett Renee, Fernie Gordon, Reid Ian C, Cameron Isobel M
From the *School of Medicine and Dentistry, and †Psychiatry Group, Division of Applied Medicine, University of Aberdeen, Aberdeen, UK.
J ECT. 2014 Sep;30(3):227-31. doi: 10.1097/YCT.0000000000000091.
This study aimed to explore the relationship of Montgomery-Åsberg Depression Rating Scale (MADRS) symptom subtypes with response to electroconvulsive therapy (ECT) and subsequent ECT treatment within 12 months.
A consecutive sample of 414 patients with depression receiving ECT in the North East of Scotland was assessed by retrospective chart review. Response rate was defined as greater than or equal to 50% decrease in pretreatment total MADRS score or a posttreatment total MADRS less than or equal to 10. Principal component analyses were conducted on a sample with psychotic features (n = 124) and a sample without psychotic features (n = 290). Scores on extracted factor subscales, clinical and demographic characteristics were assessed for association with response and subsequent ECT treatment within 12 months. Where more than 1 variable was associated with response or subsequent ECT, logistic regression analysis was applied.
MADRS symptom subtypes formed 3 separate factors in both samples. Logistic regression revealed older age and high "Despondency" subscale score predicted response in the nonpsychotic group. Older age alone predicted response in the group with psychotic features. Nonpsychotic patients subsequently re-treated with ECT were older than those not prescribed subsequent ECT. No association of variables emerged with subsequent ECT treatment in the group with psychotic features. Being of older age and the presence of psychotic features predicted response. Presence of psychotic features alone predicted subsequent retreatment.
Subscale scores of the MADRS are of limited use in predicting which patients with depression will respond to ECT, with the exception of "Despondency" subscale scores in patients without psychotic features.
本研究旨在探讨蒙哥马利-阿斯伯格抑郁评定量表(MADRS)症状亚型与电休克治疗(ECT)反应及12个月内后续ECT治疗之间的关系。
通过回顾性病历审查对苏格兰东北部414例接受ECT治疗的抑郁症患者进行连续抽样评估。反应率定义为治疗前MADRS总分降低大于或等于50%或治疗后MADRS总分小于或等于10。对有精神病性特征的样本(n = 124)和无精神病性特征的样本(n = 290)进行主成分分析。评估提取因子子量表的得分、临床和人口统计学特征与反应及12个月内后续ECT治疗的相关性。当有多个变量与反应或后续ECT相关时,应用逻辑回归分析。
MADRS症状亚型在两个样本中均形成3个独立因子。逻辑回归显示,年龄较大和“沮丧”子量表得分较高可预测非精神病性组的反应。仅年龄较大可预测有精神病性特征组的反应。接受后续ECT再治疗的非精神病性患者比未接受后续ECT治疗的患者年龄大。在有精神病性特征的组中,未发现变量与后续ECT治疗相关。年龄较大和存在精神病性特征可预测反应。仅存在精神病性特征可预测后续再治疗。
MADRS子量表得分在预测哪些抑郁症患者对ECT有反应方面作用有限,但无精神病性特征患者的“沮丧”子量表得分除外。